|
Volumn 55, Issue 2, 2000, Pages 121-124
|
The HOPE study, a two-by-two factorial clinical trial with contrasted results;L'etude clinique du mois. L'etude HOPE, un essai clinique bicephale aux resultats contrastes
a |
Author keywords
ACE inhibitor; Antioxidant; Cardiovascular risk
|
Indexed keywords
ALPHA TOCOPHEROL;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
RAMIPRIL;
ADULT;
CARDIOVASCULAR RISK;
CONTROLLED STUDY;
DIABETES MELLITUS;
HEART PROTECTION;
HUMAN;
MAJOR CLINICAL STUDY;
REVIEW;
SECONDARY PREVENTION;
AGED;
ARTICLE;
CARDIOVASCULAR DISEASE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
MIDDLE AGED;
RANDOMIZED CONTROLLED TRIAL;
RISK FACTOR;
TREATMENT OUTCOME;
AGED;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
CARDIOVASCULAR DISEASES;
DIABETES COMPLICATIONS;
HUMANS;
MIDDLE AGED;
RAMIPRIL;
RANDOMIZED CONTROLLED TRIALS;
RISK FACTORS;
TREATMENT OUTCOME;
VITAMIN E;
|
EID: 0034070844
PISSN: 00353663
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (3)
|
References (14)
|